About Contact Us Careers
Sign In

Microbiology Testing Market Size & Share, by Test Type (Bacterial, Viral, Fungal), Product (Instruments, Reagents), Diseases (Respiratory, Bloodstream Infections, Gastrointestinal, Sexually Transmitted Diseases, Urinary Tract Infection, Periodontal), Application (Pharmaceutical, Clinical, Food Testing, Energy, Chemical) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2025-2037

  • Report ID: 5065
  • Published Date: Oct 14, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2025-2037

Microbiology Testing Market size was valued at USD 4.59 billion in 2024 and is expected to cross USD 10.73 billion by the end of 2037, expanding at more than 6.9% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of microbiology testing is estimated at USD 4.84 billion.

The market growth is owing to the increasing prevalence of various infectious diseases such as sexually transmitted diseases (STDs) and human immunodeficiency virus (HIV). A WHO report estimates that over 1 million STIs are acquired each day around the world. As of 2021, 650 000 people have died from HIV-related causes and 1.5 million have contracted the virus. Microbiology testing is used to diagnose and monitor infectious diseases. The process consists of cultivating and identifying bacteria, viruses, and fungi from an individual's body, such as blood or saliva, and then determining if they are causing illness.

Moreover, the increasing urinary tract infections (UTI) is soaring the demand for microbiology testing. Prevalence of UTIs is predicted to be between 150 and 230 million worldwide every year. Number of women who suffer from UTI in the United States is 38%, making it the most common infection among women. UTIs are caused by bacteria, such as E. coli, which can be identified through microbiology testing such as Midstream urine culture (MSU).

Get more information on this report: Request Free Sample PDF

Microbiology Testing Sector: Growth Drivers and Challenges

Growth Drivers

  • Rising Importance of Food Safety Caused by The Intake of Contaminated Food- According to the WHO, 600 million people fall ill after eating contaminated food every year, and 420 000 die, resulting in 33 million years of healthy life lost. With growing awareness about food safety and hygiene, the demand for microbiology testing is increasing. These tests are used to detect the presence of harmful microorganisms in food products and other consumables, ensuring that they are safe for consumption.
  • Increase In Seasonal Influenza Cases - It is estimated that these seasonal epidemics result in approximately 3 to 5 million cases of severe illness each year worldwide. With the increasing number of seasonal influenza cases, the demand for microbiology testing is increasing as it is used to diagnose and track the spread of the influenza virus.
  • Innovative Diagnostics for Infectious Diseases - Infectious disease diagnosis has recently been revolutionized with the advent of over-the-counter and direct-to-consumer diagnostic kits and the Lyme testing algorithm by the U.S. Centers for Disease Control and Prevention (CDC).

Challenges

  • Deficiency in Test Accuracy - The accuracy of the test result is paramount in the diagnosis and treatment of infectious diseases. If the test is inaccurate or unreliable, it can lead to incorrect diagnosis and inappropriate treatment. This can have serious consequences for the patient and can also have an adverse effect on the microbiology testing market growth.
  • High cost of testing
  • Limited availability of skilled personnel

Microbiology Testing Market: Key Insights

Base Year

2024

Forecast Year

2025-2037

CAGR

6.9%

Base Year Market Size (2024)

USD 4.59 billion

Forecast Year Market Size (2037)

USD 10.73 billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Microbiology Testing Segmentation

Application (Pharmaceutical, Clinical, Food Testing, Energy, Chemical)

The pharmaceutical segment in the microbiology testing market is set to gain the largest revenue share of about 35% in the year 2037. The segment growth can be attributed to the increasing applications of microbiology testing in drug discovery, quality control and safety testing in the pharmaceutical industry. Moreover, rising R&D spending in the pharma sector is attributed to segment growth. For instance, each year, the pharma industry spends USD 100 billion on R&D.

Product (Instruments, Reagents)

The instruments segment is slated to hold about 57% share of the global microbiology testing market in the year 2037. The growth of the segment is impelled by the growing demand for rapid and automated testing methods, the increasing prevalence of infectious diseases, and the growing awareness about food safety and quality standards. Additionally, the growing demand for cost-effective methods for testing such as PCR, next-generation sequencing (NGS), and microarray-based testing and the increasing number of regulations mandating the testing in food, healthcare and other industries are also driving the instruments segment growth.

 Our in-depth analysis of the global market includes the following segments:

              Test Type
  • Bacterial
  • Viral
  • Fungal

               Product
  • Instruments
  • Reagents

            Diseases
  • Respiratory
  • Bloodstream Infections
  • Gastrointestinal
  • Sexually Transmitted Diseases
  • Urinary Tract Infection
  • Periodontal

            Application
  • Pharmaceutical
  • Clinical
  • Food Testing
  • Energy
  • Chemical

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Microbiology Testing Industry - Regional Synopsis

North American Market Forecast

Microbiology testing market in North America is projected to hold a share of about 32% by 2037. Market growth in the region is expected on account of the rising prevalence of food-borne illnesses owing to inadequate food processing. With the increasing contamination of food, there is a greater need for microbiology testing to identify and prevent these illnesses.

APAC Market Analysis

The Asia Pacific microbiology testing market is estimated to be the second largest, registering a share of about 28% by 2037. The market’s expansion is propelled by the rise in the geriatric population in the region. The increasing healthcare expenditure and rising awareness about microbiological testing benefits also influences the regional growth. The availability of advanced technologies such as PCR, and the rising number of NT-PCR testing as a result of surging COVID-19 cases, is further driving the microbiology testing market in region.

Research Nester
Get more information on this report: Request Free Sample PDF

Companies Dominating the Microbiology Testing Market

    • Neogen Corporation.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • STEMart
    • Masimo
    • Koninklijke Philips N.V.
    • GE Healthcare
    • Cerner Corporation
    • Medtronic Plc
    • Stryker
    • iHealth Labs Inc.,
    • Cisco

In the News

  • STEMart, a major source of comprehensive medical device CRO services dedicated to medical device and diagnostic clinical development has introduced sterility and microbiology testing for nonpyrogenic medical devices.
  • Neogen Corporation has introduced the Soleris NG microbial testing system, which automates the detection of microorganisms within a fraction of the time it would take to do traditional testing.

Author Credits:  Radhika Pawar


  • Report ID: 5065
  • Published Date: Oct 14, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of microbiology testing is estimated at USD 4.84 billion.

The microbiology testing market size was valued at USD 4.59 billion in 2024 and is expected to cross USD 10.73 billion by the end of 2037, expanding at more than 6.9% CAGR during the forecast period i.e., between 2025-2037. Increasing prevalence of infectious diseases, the rising demand for rapid and cost-effective tests will boost the market growth.

North America industry is projected to hold a share of about 32% by 2037, on account of the rising prevalence of food-borne illnesses in the region.

The major players in the market include Neogen Corporation., STEMart, Masimo, Koninklijke Philips N.V., GE Healthcare, Cerner Corporation, Medtronic Plc, Stryker, iHealth Labs Inc., Cisco.
Microbiology Testing Market Report Scope

Copyright © 2024 Research Nester. All Rights Reserved

logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample